Medicine & Health

Nicholas O. Davidson, MD, DSc, chief of the Division of Gastroenterology at WashU Medicine, has been honored with the 2026 Distinguished Mentor Award from the American Gastroenterological Association.

Nationally recognized physician-scientist Matthew A. Powell, MD, at WashU Medicine, will lead the effort to advance gynecologic cancer care.

Cancer cells are ravenous eaters. WashU’s Gary Patti is trying to turn their hunger against them.

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.

Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.

WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.

Milan G. Chheda, MD, at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.

Developed by WashU Medicine researchers and licensed to WashU startup Wugen, the immunotherapy is designed to treat rare and aggressive types of blood cancer.

A new tool developed by WashU Medicine researchers could allow for preemptive treatment of implant-related infections that improves outcomes and reduces patients’ emotional and financial burden.